Taiho Oncology

Develops and sells oral cancer medications for various tumors.

Founded 2002 · 350 employees · United States · Public

Listed:

Tokyo Stock Exchange: 4578

Subsidiaries:

Taiho Oncology Europe, Taiho Pharma Canada